Pseudopseudohypoparathyroidism (PPHP)

Pseudopseudohypoparathyroidism (PPHP) is a rare inherited disorder where a person looks like they have pseudohypoparathyroidism (PHP) but their blood tests for calcium, phosphate, and parathyroid hormone (PTH) are normal and their body responds normally to PTH. Orpha+1 In simple words, the body “looks” as if it has a hormone problem, but the hormone system actually works normally. PPHP is mainly a bone and body-shape condition, not a hormone-resistance condition.

Pseudopseudohypoparathyroidism (PPHP) is a very rare genetic condition. People with PPHP have the body shape and bone changes called Albright hereditary osteodystrophy (AHO). They are usually short, may be overweight, have a round face, and often have short bones in the hands and feet and small areas of extra bone under the skin. Unlike pseudohypoparathyroidism, they usually do not have hormone resistance, and their blood calcium and parathyroid hormone levels are often normal. NCBI+2Orpha+2

PPHP is caused by changes (mutations) in the GNAS gene, and it is inherited in an autosomal dominant way (a copy from one parent is enough). Whether a person gets PPHP or pseudohypoparathyroidism depends on whether the mutation comes from the mother or father, because of a process called imprinting. PPHP itself often does not need specific medical treatment, but people may need help with bone pain, joint stiffness, learning problems, and cosmetic or functional issues from bone changes. NCBI+2Jofem+2

Other names for pseudopseudohypoparathyroidism

Pseudopseudohypoparathyroidism can also be called by several other names. Different doctors or books may use different terms, but they describe the same basic condition. Orpha+1

1. Albright hereditary osteodystrophy without hormone resistance – “Albright hereditary osteodystrophy (AHO)” is the typical body shape; in PPHP this body shape exists but hormones are normal. NCBI+1

2. Albright hereditary osteodystrophy, paternally inherited form – this name stresses that the faulty gene is usually inherited from the father. Jofem+1

3. PPHP – a short form used in most medical articles. Wikipedia

4. GNAS-related Albright hereditary osteodystrophy without PTH resistance – this name focuses on the GNAS gene and the lack of hormone resistance. Orpha+1

All these names point to the same key idea: the person has the Albright hereditary osteodystrophy body features but does not have low calcium due to PTH resistance.

Types of pseudopseudohypoparathyroidism

Doctors sometimes talk about “types” of PPHP based on how the gene change appears or what the body looks like. These are not official separate diseases, but they help to describe different patterns. Orpha+1

1. Classical PPHP with typical AHO features – this is the most common form. The person is short, has a round face, short fingers (brachydactyly), and firm lumps under the skin (subcutaneous ossifications), but blood tests for calcium and PTH are normal. NCBI+1

2. PPHP with mild or incomplete AHO features – some people have only some signs, such as short fourth and fifth fingers, but normal height or no obvious facial changes. The AHO pattern is weaker, so diagnosis may be delayed. Orpha+1

3. PPHP with significant subcutaneous ossifications – in some patients, the hardest and most visible problem is abnormal bone formation in skin and soft tissues, which can cause pain and stiffness. Nature+1

4. PPHP with learning difficulties – around a minority of people with PPHP have mild intellectual disability or specific learning problems, although this is more common in pseudohypoparathyroidism type 1A. NCBI+1

5. PPHP with overlap to progressive osseous heteroplasia – some patients have very severe bone formation in soft tissues, which overlaps with another GNAS-related disorder called progressive osseous heteroplasia. Wiley Online Library+1

Even though doctors may describe these patterns, they are all part of the same genetic family of GNAS-related AHO conditions.

Causes of pseudopseudohypoparathyroidism

PPHP is almost always caused by changes in a single gene called GNAS. These changes affect how certain cells respond to hormones and how bone and soft tissues grow, but in PPHP the kidneys still respond normally to PTH. Jofem+2Orpha+2 Below are 20 detailed “cause” or mechanism points, all related to this basic genetic problem.

1. Paternally inherited mutation in the GNAS gene
   In PPHP, the faulty copy of the GNAS gene is usually inherited from the father. This is important because the body treats the father’s and mother’s copies of the gene differently (genomic imprinting). When the mutation comes from the father, it tends to cause AHO features without hormone resistance. Jofem+1

2. Loss-of-function mutation in GNAS (Gαs subunit)
   The GNAS gene gives instructions for a protein called Gs alpha (Gαs), which helps cells respond to hormone signals. A “loss-of-function” mutation means this protein does not work as it should, so certain growth and bone-development signals are disturbed. MedlinePlus+1

3. Genomic imprinting at the GNAS locus
   Genomic imprinting means that the body “switches on” or “off” certain copies of genes depending on whether they came from the mother or the father. At the GNAS region, some tissues mainly use the mother’s copy, while others use both. This special pattern explains why the same mutation can cause PHP1A if inherited from the mother and PPHP if inherited from the father. PMC+1

4. Heterozygous GNAS variants
   People with PPHP usually have a heterozygous mutation, which means one normal and one mutated copy of GNAS. This half-strength activity leads to body changes but still allows normal PTH response in the kidneys. ScienceDirect+1

5. Point mutations in coding exons of GNAS
   Many PPHP cases are due to small changes in the DNA “letters” in exons (coding parts) of GNAS. These point mutations can change a single amino acid in the Gs alpha protein and reduce its function. PMC+1

6. Large deletions or rearrangements of the GNAS gene
   In some families, larger chunks of the GNAS gene are missing or rearranged. These structural changes can also cause PPHP when inherited from the father, leading to AHO features. Nature+1

7. De novo (new) GNAS mutations
   Sometimes the mutation is not inherited from either parent but appears for the first time in the child (de novo). This still causes PPHP if it behaves like a paternal-type mutation in relevant tissues. Children’s Hospital of Philadelphia+1

8. Reduced Gs alpha activity in bone and soft tissues
   Because Gs alpha activity is reduced in bone-forming and soft-tissue cells, normal growth signals are changed. This leads to short bones, especially in the hands and feet, and sometimes abnormal bone deposits in the skin. NCBI+1

9. Preserved Gs alpha activity in kidney tubule cells
   In kidney cells, only the mother’s copy of GNAS is mainly active. Since that maternal copy is normal in PPHP, the kidneys still respond to PTH. This explains why calcium and phosphate levels are normal and there is no hormone resistance. Wikipedia+1

10. Autosomal dominant inheritance pattern
    PPHP usually follows an autosomal dominant pattern. This means a person with the mutation has a 50% chance of passing it to each child, depending on whether the copy is paternal or maternal in the child. Orpha+1

11. Family history of AHO or PHP1A
    In many families, some members have PHP1A (with hormone resistance) and others have PPHP (without resistance). This mixed picture happens because the same mutation behaves differently depending on from which parent it is inherited. PMC+1

12. Epigenetic changes around GNAS
    Sometimes, chemical tags (like methylation) around the GNAS region are abnormal. These epigenetic changes can affect gene activity and contribute to AHO-like features and PPHP-type presentations. Nature+1

13. Mosaicism for GNAS mutations
    Mosaicism means not all cells in the body carry the mutation. In some people, only a proportion of cells have the faulty GNAS, leading to milder or uneven AHO features that still fit PPHP. ScienceDirect+1

14. Interaction with other hormonal pathways
    Gs alpha is used by many hormone receptors, not just PTH. Partial loss of its function can mildly affect other hormones (like TSH or gonadotropins), changing growth or body composition and shaping the PPHP phenotype. Nature+1

15. Abnormal bone growth regulation
    Because GNAS is important in bone-forming cells, its reduced activity leads to early closure of growth plates and short bones, especially in the hands and feet. This disturbed bone growth is a direct cause of brachydactyly and short stature. NCBI+1

16. Abnormal soft tissue ossification
    Some PPHP patients develop bone in places where bone does not usually form (heterotopic ossification) in fat or muscle. The altered Gs alpha signaling may encourage this abnormal bone formation. Wiley Online Library+1

17. Genetic modifiers and background genes
    Not everyone with the same GNAS mutation looks the same. Other genes in the person’s DNA can modify how strong the AHO features are, so they act as “modifiers” of the PPHP phenotype. Nature+1

18. Environmental influences on growth and weight
    While the base cause is genetic, lifestyle factors such as diet and physical activity can affect how much obesity or joint stiffness a person with PPHP develops over time. Nature+1

19. Delayed diagnosis and secondary changes
    If PPHP is not recognized early, abnormal bone growth and joint problems may progress, leading to more severe stiffness and pain that become part of the clinical picture, even though they are secondary to the underlying gene defect. malacards.org+1

20. Shared mechanisms with pseudohypoparathyroidism
    PPHP and PHP1A share the same basic GNAS defect; the main difference is whether the mutation is on the maternal or paternal allele in key tissues. This shared mechanism explains why their body shapes are almost identical, while blood tests differ. PMC+1

Symptoms of pseudopseudohypoparathyroidism

People with PPHP mainly have physical features and bone changes, not severe hormone problems. Symptoms usually appear in childhood and remain throughout life. NCBI+2Orpha+2

1. Short stature
   Many people with PPHP are shorter than average for their age and family. This is due to early closure of growth plates in the bones, especially in the arms and legs. NCBI+1

2. Rounded face and full cheeks
   A typical rounded face with full cheeks is common and is part of the Albright hereditary osteodystrophy pattern. This facial shape can help doctors suspect the diagnosis. NCBI+1

3. Short fingers and toes (brachydactyly)
   The bones of the hands and feet, especially the fourth and fifth metacarpals and metatarsals, are often short. This makes the fingers and toes appear stubby or shortened. NCBI+1

4. Subcutaneous ossifications (hard lumps under the skin)
   Some patients develop small, hard nodules under the skin or in muscles. These are areas where bone has formed outside the skeleton and can sometimes be painful or limit movement. Nature+1

5. Stocky body build
   The body may look broad and stocky, with a shorter trunk and limbs. This stocky habitus is another classic AHO feature seen in PPHP. NCBI+1

6. Early-onset obesity or tendency to gain weight
   Many children with AHO/PPHP gain weight easily, especially around the trunk. This may be due to changes in energy balance, decreased activity from joint pain, or subtle hormone effects. NCBI+1

7. Joint stiffness and limited movement
   Abnormal bone formation and short bones can cause stiff joints and reduced range of motion, especially in elbows, wrists, and ankles. This can affect daily activities and sports. Wiley Online Library+1

8. Bone or joint pain
   Some people experience pain in bones or joints, often linked to ossifications or abnormal joint loading due to short bones and altered bone shape. malacards.org+1

9. Dental problems
   PPHP may be associated with dental issues like delayed tooth eruption or enamel problems, because GNAS is also involved in tooth development. NCBI+1

10. Learning difficulties or mild intellectual disability
    A minority of patients have mild learning problems or developmental delay. This is more prominent in PHP1A but can also appear in PPHP families. NCBI+1

11. Relative macrocephaly (large head compared to body)
    Some children have a head size that looks relatively large for their short body, which is another described AHO feature. NCBI+1

12. Reduced growth in childhood
    Parents and doctors may notice that the child’s height curve falls below expected percentiles over time, even if birth length was normal. NCBI+1

13. Cosmetic concerns and low self-esteem
    Because of short stature, body shape, and facial features, some people with PPHP may feel self-conscious, especially during adolescence, which can affect mood and social life. malacards.org+1

14. Mild muscle weakness or fatigue
    Joint stiffness and abnormal bone structure can cause muscles to work less efficiently, leading to tiredness or weakness with exercise. malacards.org+1

15. Rare neurological symptoms
    Serious neurological signs like seizures are uncommon in PPHP because calcium levels are usually normal, but they may occur if there are overlapping conditions or other causes. jbsr.be+1

Diagnostic tests for pseudopseudohypoparathyroidism

Diagnosis of PPHP is based on physical features, normal calcium–phosphate–PTH labs, and confirmation of a GNAS mutation, usually inherited from the father. Orpha+2Wikipedia+2 Doctors also need to rule out pseudohypoparathyroidism and hypoparathyroidism, which have similar looks but different blood tests. Below are 20 tests, grouped by type.

A. Physical examination tests

1. General physical examination
   The doctor looks at overall height, weight, body proportions, and facial appearance. Short stature, stocky build, and a round face with full cheeks suggest an AHO pattern compatible with PPHP. NCBI+1

2. Hand and finger inspection
   The hands are carefully observed for short fourth and fifth fingers and a shortened fourth metacarpal. This can be seen when the person makes a fist and the knuckles of the ring finger look lower. NCBI+1

3. Growth chart and body proportion assessment
   Height and weight are plotted on a growth chart and compared with age and family height. Disproportionately short limbs or a drop in height percentile over time supports the diagnosis. NCBI+1

4. Skin and subcutaneous tissue examination
   The doctor feels under the skin for firm nodules that may represent ossifications. Their presence in typical locations (such as over elbows or knees) supports a GNAS-related disorder like PPHP. Nature+1

5. Neurological and developmental assessment
   Basic tests of reflexes, coordination, speech, and learning are performed. Subtle developmental delay or learning problems may be documented, adding to the overall clinical picture. NCBI+1

B. Manual or bedside functional tests

6. Joint range-of-motion testing
   The doctor gently moves the patient’s joints through their full range. Limitation, stiffness, or pain in elbows, wrists, or ankles can reflect bone and soft-tissue changes seen in PPHP. malacards.org+1

7. Anthropometric measurements of hands and feet
   Measuring hand length, finger length, and the distance between certain points helps to document brachydactyly. These simple manual measurements can be compared against standard charts. ScienceDirect+1

8. Dental inspection with basic tools
   A simple oral exam using a light and mirror can show delayed tooth eruption or enamel problems. These signs support the broader AHO phenotype in PPHP. NCBI+1

9. Clinical tests for hypocalcemia signs (Chvostek and Trousseau)
   Although calcium is usually normal in PPHP, doctors may still check facial muscle twitching (Chvostek sign) or hand spasm (Trousseau sign). Their absence plus the AHO body features suggests PPHP rather than PHP1A. Orpha+1

C. Laboratory and pathological tests

10. Serum calcium level
    Blood calcium is measured. In PPHP, calcium is usually normal, in contrast to pseudohypoparathyroidism, where calcium is typically low. This normal result is a key clue. eMedicine+1

11. Serum phosphate (phosphorus) level
    Phosphate is usually normal in PPHP. In PHP1A, phosphate tends to be high. Normal phosphate together with AHO features points towards PPHP. PMC+1

12. Parathyroid hormone (PTH) level
    In PPHP, PTH levels are typically normal because the body responds to PTH properly. In PHP, PTH is high due to resistance. A normal PTH in a person with AHO phenotype supports PPHP. PMC+1

13. Vitamin D level
    Vitamin D is checked to rule out vitamin D deficiency, which can also cause bone problems or hypocalcemia. Normal vitamin D helps to narrow the diagnosis. PMC+1

14. Serum magnesium and kidney function tests
    Magnesium and kidney tests (like creatinine) are measured to exclude kidney disease or electrolyte problems that could affect calcium levels. Normal results support a genetic, not kidney-related, cause. eMedicine+1

15. Thyroid-stimulating hormone (TSH) and thyroid hormone levels
    Because GNAS defects can sometimes affect thyroid signaling in related disorders, thyroid tests may be done. Normal thyroid tests in PPHP help differentiate it from PHP1A, where TSH resistance can occur. Nature+1

16. Genetic testing for GNAS mutations
    DNA testing looks directly for mutations in the GNAS gene. Finding a loss-of-function variant supports PPHP or PHP1A; when combined with normal calcium–phosphate–PTH and paternal inheritance, it confirms PPHP. PMC+2PLOS+2

17. Methylation or imprinting studies at the GNAS locus
    Specialized lab tests examine the pattern of methylation around the GNAS gene. Abnormal imprinting patterns can help classify the exact type of GNAS-related disorder and explain why PPHP features occur. Nature+1

D. Electrodiagnostic tests

18. Electrocardiogram (ECG)
    An ECG is sometimes done to check heart rhythm and the QT interval, especially if there is any concern for calcium imbalance. In PPHP, ECG is usually normal, which again supports normal calcium handling. Cleveland Clinic+1

19. Nerve conduction studies (in selected cases)
    If a person has unexplained numbness, tingling, or weakness, nerve conduction studies may be done. They help rule out other nerve diseases and see whether any nerve damage is due to bone or joint changes rather than low calcium. malacards.org+1

E. Imaging tests

20. Hand X-ray and skeletal imaging
    X-rays of the hands are classic in PPHP diagnosis. They show shortened fourth and fifth metacarpals and other bone changes typical of AHO. Additional skeletal X-rays can reveal subcutaneous ossifications and abnormal bone shape. ScienceDirect+1

21. Brain imaging (CT or MRI) when needed
    Brain CT or MRI may be done if there are neurological symptoms or to look for calcifications in structures like the choroid plexus. These findings are more often discussed in AHO/PHP but may be checked in complex PPHP cases. ResearchGate+1

22. Bone age X-ray
    X-rays of the hand and wrist can be compared with bone age charts. They may show advanced or altered bone age and early closure of growth plates, supporting a diagnosis of AHO-type disorder. NCBI+1

23. Ultrasound or CT of soft tissues
    Imaging of subcutaneous nodules can show calcified or ossified areas in the soft tissues. These pictures help confirm that the hard lumps felt on exam are due to bone formation. Wiley Online Library+1

24. Whole-body or targeted skeletal survey
    In severe or unclear cases, a series of X-rays may be taken to map bone deformities and soft-tissue ossifications throughout the body. This provides a full picture of the structural impact of PPHP. jbsr.be+1

Treatment overview

There is no cure and no special drug that directly “fixes” PPHP. Management is usually supportive. The main goals are to reduce pain, protect joints, support growth and learning, manage weight, and treat any related problems like ectopic bone formation or dental issues. Many experts recommend regular follow-up in a multidisciplinary clinic, with endocrinologists, orthopedists, dentists, physiotherapists, and psychologists working together. Nature+2Lippincott Journals+2

Very important: the medicines and doses below are general examples only, based mainly on FDA drug labels and clinical guidelines, not personal medical advice. Never start, stop, or change a medicine or supplement without a doctor. Drug labels on accessdata.fda.gov and national guidelines give the official, most up-to-date safety information and dosing rules. FDA Access Data+3FDA Access Data+3FDA Access Data+3

---

Non-pharmacological treatments

1. Genetic counselling
   Genetic counselling helps the person and family understand how PPHP happens, the risk of passing it to children, and differences between PPHP and pseudohypoparathyroidism. The counsellor explains test results in simple language and discusses options for family planning. This support can reduce anxiety and help families make informed choices about future pregnancies and testing of other relatives. NCBI+2Orpha+2

2. Regular multidisciplinary follow-up
   Because PPHP can affect bones, joints, learning, and appearance, ongoing care in a clinic with several specialists is very useful. The team may include an endocrinologist, orthopaedic surgeon, geneticist, dentist, physiotherapist, and psychologist. Regular checks allow early detection of complications like severe joint stiffness or painful ossifications, so treatment and support can start before problems become severe. Nature+2Lippincott Journals+2

3. Physical therapy (physiotherapy)
   Physical therapy focuses on stretching, strengthening, and posture training to keep muscles flexible and joints moving well. Gentle, regular exercises can reduce stiffness from ectopic bone formation and abnormal bone shape, improve balance, and lower the risk of falls. The therapist can also teach safe ways to walk, climb stairs, or lift objects that protect joints from extra stress. Orpha+2Contact+2

4. Occupational therapy
   Occupational therapists help people manage daily jobs like dressing, writing, cooking, and using a computer. They can suggest adaptive tools, like special grips or cutlery, for people with short fingers or reduced hand movement. By breaking tasks into small steps and adjusting the environment, occupational therapy supports independence at home, in school, and at work. Contact+1

5. Pain management with non-drug methods
   Some people with PPHP have chronic bone and joint pain due to deformities and extra bone growth. Heat packs, cold packs, gentle stretching, massage, relaxation breathing, and pacing of activities can reduce pain without extra medicine. Learning to balance rest and movement, and using good posture and supportive shoes, may lower daily pain and improve function. malacards.org+1

6. Weight management and lifestyle coaching
   Obesity is very common in AHO and PPHP, and extra weight makes pain and joint problems worse. A nutritionist and lifestyle coach can help build a slow, steady weight-control plan with realistic goals, focusing on more whole foods and gradual activity increases rather than strict diets. Even small weight loss can reduce joint stress and improve energy. Contact+2ScienceDirect+2

7. Nutritional counselling
   Dietitians can create a balanced eating plan that supports bone health, healthy weight, and heart health. They often stress calcium-rich but not calorie-dense foods, vitamin D sources, lean protein, fiber, and limited sugary, fried, or ultra-processed foods. Teaching the family how to read food labels and plan meals helps maintain long-term healthy habits. Cleveland Clinic+1

8. Special education and learning support
   A minority of people with PPHP have developmental delay or learning difficulties. Early assessment by a psychologist or educational specialist allows tailoring of school support, such as extra time in exams, speech or language therapy, or one-to-one teaching. This can improve school performance, confidence, and later work opportunities. Contact+1

9. Psychological counselling and family support
   Body image problems, bullying, or anxiety about a rare genetic condition are common. Psychologists or counsellors can offer cognitive behavioural therapy, coping skills, and support groups for the child and parents. Talking openly about feelings and using problem-solving strategies can reduce depression and social withdrawal and improve quality of life. Nature+2Lippincott Journals+2

10. Orthopaedic assessment and bracing
    Orthopaedic doctors can monitor bone growth, alignment, and joint function. In some cases they may suggest braces, shoe inserts, or supports that improve leg alignment and lower pain during walking. Early use of such devices can delay or prevent more serious deformities and reduce the need for major surgery later in life. Orpha+2Orthobullets+2

11. Dental and orthodontic care
    Dental enamel defects and crowded teeth can occur with AHO-like conditions. Regular dental visits, fluoride treatments, and orthodontic correction can protect teeth from decay and improve chewing and appearance. Good dental care also prevents infections that could worsen general health and self-esteem. Wikipedia+1

12. Surgical removal of painful subcutaneous ossifications
    Some people develop hard bone lumps under the skin that are painful or limit movement. In selected cases, surgeons may remove these lumps to relieve pain and improve motion or appearance. Because bone growth can recur, decisions about surgery are individual and usually follow careful imaging and discussion with the patient and family. Orpha+2Orpha+2

13. Assistive devices and mobility aids
    People with PPHP may benefit from custom shoes, walking sticks, or other devices that improve safety and comfort. These aids can reduce fatigue, lower pain in knees, hips, and spine, and allow longer walking distances. Occupational or physical therapists usually help choose and adjust these tools. Contact+1

14. Sleep hygiene support
    Chronic pain, obesity, and anxiety can disturb sleep. Simple sleep hygiene measures—regular bedtimes, limiting screens before bed, a dark quiet bedroom, and relaxation routines—often improve sleep quality. Better sleep helps mood, attention, and pain tolerance during the day. Nature+1

15. Social work and community support services
    Social workers can help families access disability benefits, school support, transport help, and local support groups. They can also coordinate care between hospital and community services. This reduces the burden on caregivers and ensures that no important support is missed. Nature+1

16. Patient and family education programmes
    Education sessions explain PPHP, its inheritance, and common complications in simple language. When people understand what to watch for, they can seek timely help for new pain, changes in movement, or learning difficulties. Education improves adherence to therapy and empowers families to speak up in medical visits. NCBI+2Orpha+2

17. Safe, regular physical activity
    Gentle activities like walking, swimming, and cycling help maintain muscle strength and joint mobility while avoiding high impact on fragile joints. Exercise also supports healthy weight and mood. Plans should be personalised, starting slowly and increasing as tolerated, ideally under physiotherapy guidance. Contact+1

18. Fall-prevention and home safety modifications
    Because joint problems and short stature can affect balance, small home adjustments—grab rails, non-slip mats, good lighting, and clutter-free floors—reduce the risk of falls. A physiotherapist or occupational therapist can assess the home and suggest simple, low-cost changes. Contact+1

19. Vocational counselling and career planning
    For older adolescents and adults, counselling about realistic job choices that fit physical abilities is helpful. Careers that avoid heavy lifting or long standing might be better suited. Planning early helps people choose training or education paths that support independence and financial security. Contact+1

20. Online support groups and rare disease networks
    Connecting with other families with PPHP or related conditions helps reduce isolation and offers practical tips about daily life, school, and work. Many rare disease organisations provide trustworthy information, advocacy, and opportunities to join research studies. National Organization for Rare Disorders+1

---

Drug treatments

Important: No medicine is specifically approved “for PPHP” itself. The drugs below are used for symptoms or associated problems (such as pain or hypothyroidism) and must always be prescribed and supervised by a doctor. Doses are general examples from FDA labels and may differ by country and patient. Orpha+2Nature+2

1. Acetaminophen (paracetamol)
   Acetaminophen is a common pain and fever medicine used for mild to moderate bone or joint pain. Adult labels often suggest 325–1000 mg every 4–6 hours as needed, not exceeding 4,000 mg per day from all sources. It works mainly by blocking pain signals in the brain, not by reducing inflammation. High doses or long-term overuse can damage the liver, so careful total daily dosing is essential. FDA Access Data+1

2. Ibuprofen (NSAID)
   Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) often used when joint pain has an inflammatory element. Adults commonly take 200–400 mg every 4–6 hours as needed, using the smallest effective dose. It works by blocking cyclo-oxygenase (COX) enzymes and lowers prostaglandin production to reduce pain and swelling. Side effects include stomach irritation, ulcers, kidney strain, and increased risk of heart problems, especially with long-term high doses. FDA Access Data+2FDA Access Data+2

3. Naproxen (NSAID)
   Naproxen is another NSAID used for longer-lasting pain relief from bone and joint discomfort. Typical adult doses from labels range around 250–500 mg twice daily with food, although exact dosing is individual. Like ibuprofen, it inhibits COX enzymes to reduce inflammation. It can cause stomach bleeding, ulcers, kidney problems, and cardiovascular risks; people with heart disease, kidney disease, or ulcer history need special caution. FDA Access Data+2FDA Access Data+2

4. Topical NSAID gels (e.g., diclofenac gel)
   Topical NSAID gels are rubbed onto painful joints to give local anti-inflammatory effects with less systemic exposure. They reduce prostaglandin production in tissues under the skin. Possible side effects are skin irritation and, rarely, systemic NSAID risks if used over large areas for long periods. They may help mild joint pain associated with abnormal mechanics in PPHP. BMJ Best Practice+1

5. Low-dose opioid combinations (only in selected severe cases)
   In rare, severe pain not controlled by other treatments, doctors might consider short-term use of opioid/acetaminophen combinations under strict supervision. These drugs work by binding to opioid receptors in the brain and spinal cord to reduce pain perception. They carry high risks of dependence, drowsiness, constipation, and breathing problems, so they are generally avoided if possible and used at the lowest effective dose for the shortest time. FDA Access Data+1

6. Muscle relaxants (e.g., baclofen, tizanidine) – specialist use
   If spasm or increased muscle tone around abnormal joints worsens pain, specialists may use muscle relaxants. They act on the spinal cord or brain to reduce nerve signals that cause muscle tightening. Side effects include drowsiness, dizziness, and low blood pressure. These drugs are usually reserved for specific cases and require careful dose adjustment and monitoring. StatPearls+1

7. Vitamin D supplements
   While PPHP usually has normal calcium and PTH, some people may still have low vitamin D, especially if they avoid sun or have obesity. Vitamin D3 supplements (for example, 400–2000 IU daily in many guidelines) help maintain bone health by improving calcium absorption from the gut. Too much vitamin D can cause high calcium and kidney problems, so levels are checked regularly. Cleveland Clinic+2National Organization for Rare Disorders+2

8. Calcium supplements
   Calcium carbonate or calcium citrate may be used if dietary calcium is low or if there is a related calcium imbalance in the family (for example, in relatives with pseudohypoparathyroidism). Typical doses vary widely (e.g., 500–1200 mg elemental calcium per day) and must include dietary intake in the calculation. Excess calcium can cause constipation, kidney stones, and vascular calcification. eMedicine+2BMJ Best Practice+2

9. Levothyroxine (for associated hypothyroidism in relatives)
   Levothyroxine is a synthetic thyroid hormone used when people with related GNAS disorders develop hypothyroidism. It replaces missing thyroid hormone and normalises metabolism, growth, and energy. Doses are carefully calculated by weight, age, and lab tests (TSH, T4), and adjusted every few weeks. Side effects of too high a dose include palpitations, weight loss, anxiety, and bone loss. jcrpe.org+2FDA Access Data+2

10. Growth hormone (GH) therapy – for specific related disorders
    In some pseudohypoparathyroidism patients with growth hormone deficiency, GH therapy improves height. In PPHP itself, GH is not standard but might be discussed if there is proven GH deficiency. GH is injected under the skin and stimulates growth plates and protein synthesis. Side effects may include fluid retention, joint pain, and increased intracranial pressure, so it is used only after specialist assessment. Nature+2National Organization for Rare Disorders+2

11. Statins (for obesity-related dyslipidemia)
    In older adolescents and adults with obesity and high cholesterol, statins may be used to reduce cardiovascular risk. They work by blocking HMG-CoA reductase in the liver, lowering LDL cholesterol and stabilising plaques. Side effects can include muscle pain, rare liver injury, and, very rarely, serious muscle breakdown. Use is based on general cardiovascular guidelines, not PPHP-specific evidence. National Organization for Rare Disorders+1

12. Metformin (for insulin resistance or type 2 diabetes)
    Obesity and reduced activity can lead to insulin resistance or diabetes. Metformin improves insulin sensitivity and reduces liver glucose production. Typical adult starting doses are 500 mg once or twice daily with food, increased slowly. Common side effects are stomach upset and diarrhoea; rare risks include lactic acidosis in people with kidney or liver disease. National Organization for Rare Disorders+1

13. Antidepressants (e.g., SSRIs) for mood disorders
    Chronic pain and body image concerns can lead to depression and anxiety. Selective serotonin reuptake inhibitors (SSRIs) increase serotonin levels in the brain and can improve mood, sleep, and energy. Side effects may include nausea, headache, and sexual dysfunction. These medicines must be prescribed by a mental-health-trained doctor and combined with psychological therapy. Nature+1

14. Low-dose anxiolytics – very cautious, short term
    In severe, short-term anxiety (for example, around surgery or procedures), doctors may briefly use calming medicines like benzodiazepines. They act on GABA receptors to reduce nervous system activity. Because they can cause dependence, drowsiness, and falls, they are used very sparingly and never as a long-term solution. Lippincott Journals+1

15. Bisphosphonates – for specific bone density problems
    If a person with PPHP also has low bone density or fragility fractures, a specialist might consider bisphosphonates (like alendronate). These drugs bind to bone and slow bone breakdown by osteoclasts. Side effects include stomach irritation, bone or joint pain, and rare jaw bone problems. They are usually reserved for clear osteoporosis and monitored closely. Orpha+2ScienceDirect+2

16. Topical anaesthetic creams
    For painful injections or minor procedures, topical anaesthetic creams numb the skin. They block sodium channels in nerve endings, so pain signals do not reach the brain. Side effects are usually mild skin irritation. These creams do not treat PPHP itself but make medical care less stressful, especially for children. StatPearls+1

17. Proton pump inhibitors (PPIs) – for NSAID stomach protection
    If long-term NSAIDs are needed for pain, PPIs like omeprazole may protect the stomach by blocking acid production in parietal cells. This lowers the risk of ulcers and bleeding. Side effects can include headaches, diarrhoea, and, with long-term use, possible changes in mineral absorption. PPIs are only used when clearly indicated. BMJ Best Practice+1

18. Anticonvulsants for neuropathic pain (e.g., gabapentin) – selected cases
    If abnormal bone compresses nerves and causes burning or shooting nerve pain, medications like gabapentin may be considered. They modulate calcium channels in nerve cells and reduce abnormal firing. Side effects include dizziness, fatigue, and weight gain. These drugs are used after specialist evaluation and are not routine in PPHP. malacards.org+1

19. Topical capsaicin cream
    Capsaicin cream depletes substance P from pain-transmitting nerve endings in the skin, reducing pain over time with regular use. It may help localised chronic pain around small ossifications or painful scars. Burning or stinging on the skin is common but usually improves with continued use. StatPearls+1

20. Allergy and asthma medicines (if needed)
    People with PPHP can, like anyone else, have asthma or allergies. Inhaled bronchodilators, inhaled steroids, or antihistamines are used according to standard guidelines. They act on airway smooth muscle or immune cells to reduce inflammation and constriction. These conditions are managed as usual and are not specific to PPHP. StatPearls+1

---

Dietary molecular supplements

Always discuss supplements with a doctor. “Natural” does not mean safe, and some products interact with medicines or affect surgery and anaesthesia. StatPearls+1

1. Vitamin D3
   Vitamin D3 supports calcium absorption from the gut and helps bone mineralisation. In deficiency, supplements can correct low levels and improve muscle function and fall risk. Typical doses vary (for example, 400–2000 IU daily, or higher short-term under medical advice) depending on blood levels. Too much vitamin D can cause high calcium, nausea, confusion, and kidney damage, so blood tests and doctor guidance are vital. Cleveland Clinic+2National Organization for Rare Disorders+2

2. Calcium (diet plus supplements)
   Calcium is a major building block of bone. When diet is low in calcium, modest supplements help maintain bone strength. Most adults need around 1000–1200 mg elemental calcium per day from diet plus supplements, but exact needs depend on age and sex. Taking high doses without need can cause constipation, kidney stones, and possible heart risks. eMedicine+1

3. Magnesium
   Magnesium is a mineral involved in bone structure, muscle relaxation, and nerve function. Low magnesium can worsen muscle cramps and may affect vitamin D and calcium use. Supplement doses vary (for example, 100–400 mg/day), and too much can cause diarrhoea and, in kidney disease, dangerous high magnesium levels. Green vegetables, nuts, and whole grains are good food sources. StatPearls+1

4. Vitamin K2
   Vitamin K2 helps guide calcium into bones rather than soft tissues by activating proteins like osteocalcin. Some studies suggest it may support bone density when combined with vitamin D and calcium. Doses in supplements are often 45–200 µg/day, but long-term safety and benefit in rare diseases like PPHP are not well studied. People on blood thinners must be especially careful. StatPearls+1

5. Collagen peptides
   Collagen supplements provide amino acids used to build cartilage, bone matrix, and connective tissue. Small studies show improved joint comfort in osteoarthritis when taken for several months. Typical doses are about 5–10 g per day dissolved in water. Side effects are usually mild (bloating or taste issues). They should be seen as an add-on, not a replacement for medical treatment. ScienceDirect+1

6. Omega-3 fatty acids (fish oil or algae oil)
   Omega-3 fats (EPA/DHA) have anti-inflammatory effects by altering cell membrane composition and eicosanoid production. They may modestly reduce joint pain and improve heart health, which is important in people with obesity. Common supplemental doses are around 500–1000 mg EPA/DHA per day. Side effects include fishy burps and, at higher doses, a slightly increased bleeding tendency. StatPearls+1

7. Probiotics
   Probiotics are live “good” bacteria that support gut health and may modestly influence metabolism and inflammation. They are often used to improve digestion, especially when people take multiple medicines. Different strains and doses are used, so evidence is variable. Side effects are usually mild gas or bloating; people with severe immune problems should be cautious. StatPearls+1

8. Multivitamin with trace elements
   A standard multivitamin provides small amounts of many vitamins and minerals, acting as a “safety net” when diet is unbalanced. It does not replace healthy food but can help cover gaps in picky eaters or people with reduced appetite. High-dose or specialised formulas should only be used under medical advice to avoid excess intake. National Organization for Rare Disorders+1

9. Curcumin (turmeric extract)
   Curcumin has anti-inflammatory and antioxidant actions in lab studies. It may mildly reduce joint pain in some people. Typical supplement doses range from 500–1000 mg/day, usually with a compound that improves absorption (like piperine). It can interact with blood thinners and cause stomach upset in some people. Evidence in PPHP is indirect, from general pain studies. StatPearls+1

10. Coenzyme Q10 (CoQ10)
    CoQ10 is an antioxidant involved in energy production inside mitochondria. It may help with fatigue and muscle function in some conditions. Doses around 100–200 mg/day are common in supplements. Side effects are usually mild, such as stomach upset or insomnia if taken late. Its use in PPHP is supportive, not disease-specific. StatPearls+1

---

Immunity-booster, regenerative, and stem-cell-related drugs

There are no specific regenerative or stem cell drugs approved for PPHP. The options below relate to general bone health or experimental techniques used in other bone disorders. They should only be considered in research settings or when clearly indicated for another diagnosis. Nature+2Lippincott Journals+2

1. Teriparatide (PTH 1-34)
   Teriparatide is a synthetic form of parathyroid hormone fragment used in severe osteoporosis to stimulate new bone formation. It activates osteoblasts more than osteoclasts when given intermittently by daily injection. It is not licensed for PPHP, but in theory could be considered in adults with very low bone density and fractures under osteoporosis guidelines. Risks include high calcium, nausea, and rare concerns about bone tumours in animals. StatPearls+1

2. Romosozumab
   Romosozumab is a monoclonal antibody against sclerostin, increasing bone formation and decreasing bone resorption. It is approved for high-risk osteoporosis in some adults, given as monthly injections for a limited time. It is not studied in PPHP and carries a warning for possible increased cardiovascular events. Any use would follow strict osteoporosis criteria, not PPHP alone. StatPearls+1

3. Mesenchymal stem-cell therapies (experimental)
   Mesenchymal stem cells from bone marrow or fat can form bone, cartilage, and other tissues. Experimental treatments are being studied for certain bone defects and joint damage. In PPHP, this approach remains theoretical and should only occur in regulated clinical trials, because long-term safety, tumour risk, and effectiveness are still unclear. StatPearls+1

4. Platelet-rich plasma (PRP)
   PRP is prepared from the patient’s own blood and contains concentrated platelets and growth factors. It is injected into joints or soft tissues to try to support healing and reduce pain. Evidence is mixed even for common conditions like osteoarthritis, and there are no studies specific to PPHP. It should be viewed as experimental and optional. StatPearls+1

5. Biologic anti-inflammatory agents (for coexisting autoimmune disease)
   If a person with PPHP also has an autoimmune arthritis, biologic medicines like TNF-alpha blockers or IL-6 blockers may be used under rheumatology care. These drugs target specific inflammatory pathways and can strongly reduce joint damage. They suppress the immune system and increase infection risk, so they are not used lightly and have no PPHP-specific approval. StatPearls+1

6. General immune-supportive measures (vaccination, good nutrition)
   The safest ways to support immunity in PPHP are regular age-appropriate vaccines, good handwashing, adequate sleep, balanced diet, and exercise. These lower infection risk and help the body handle stress and surgery. They are far safer and better studied than unproven “immune booster” pills. StatPearls+1

---

Surgeries and procedures

1. Excision of subcutaneous ossifications
   When bony lumps under the skin become painful, infected, or severely limit movement, surgeons may remove them. The procedure involves cutting out the lump, smoothing surrounding tissue, and closing the wound. It is done mainly to relieve pain or restore function, not to cure PPHP. Bone may regrow over time, so surgery is considered carefully. Orpha+2Orpha+2

2. Corrective orthopaedic surgery for deformity
   Severe bone deformities, such as significant leg misalignment or hand deformities causing functional loss, may need corrective surgery. Techniques include cutting and realigning bone (osteotomy) and stabilising with plates or rods. The aim is to improve walking, reduce pain, and allow better use of hands. Recovery involves physiotherapy and can be lengthy. Orpha+1

3. Dental and maxillofacial surgery
   In some individuals, jaw or teeth abnormalities may require surgical correction, such as tooth extractions, jaw alignment, or bone reshaping. These procedures improve chewing, speech, oral hygiene, and appearance. Proper planning with orthodontists and maxillofacial surgeons is important to avoid nerve and tooth damage. Wikipedia+1

4. Bariatric (weight-loss) surgery – selected adults
   In adults with severe obesity and obesity-related complications not improved by lifestyle or medicines, bariatric surgery may be considered. It reduces stomach size or changes gut anatomy to reduce calorie absorption. This can greatly improve mobility and metabolic health but carries surgical risks and requires lifelong diet changes. It is not PPHP-specific and must follow national obesity guidelines. National Organization for Rare Disorders+1

5. Nerve decompression surgery
   If extra bone or deformity compresses nerves, causing severe pain, weakness, or numbness, surgeons may perform decompression to free the nerve. This may involve removing bone or fibrous tissue around the nerve. The goal is to relieve nerve pressure and prevent permanent damage. As with all surgery, careful risk-benefit analysis is needed. malacards.org+1

---

Prevention strategies

Because PPHP is genetic, we cannot prevent the condition itself, but we can often prevent or reduce complications. NCBI+1

1. Early diagnosis and family screening – recognising PPHP early and checking close relatives lets families plan care and watch for complications sooner. NCBI+1

2. Maintaining a healthy weight – avoiding rapid weight gain in childhood and managing obesity reduces joint stress, pain, and metabolic complications. Contact+1

3. Encouraging regular low-impact exercise – steady activity preserves joint range of motion, muscle strength, and balance, lowering fall and fracture risk. Contact+1

4. Ensuring adequate vitamin D and calcium intake – correct deficiency to support bone strength, under medical supervision. Cleveland Clinic+1

5. Protecting joints from overuse – avoiding heavy lifting, high-impact sports, and repetitive joint strain reduces wear on already abnormal bones. ScienceDirect+1

6. Regular dental and eye checks – early detection of enamel problems or visual issues allows prompt treatment and can prevent long-term complications. Wikipedia+1

7. Monitoring learning and behaviour early – screening for learning difficulties or behaviour problems in young children supports earlier interventions and better school outcomes. Contact+1

8. Avoiding smoking and limiting alcohol in adults – both can weaken bones and damage heart and lung health, which is especially harmful in people with limited mobility. StatPearls+1

9. Keeping vaccinations up to date – prevents infections that could complicate surgeries or long hospital stays. StatPearls+1

10. Following a regular follow-up schedule – planned check-ups help catch new issues like pain, deformity, or weight problems before they become severe. Nature+1

---

When to see doctors

People with PPHP should see a doctor regularly as part of planned follow-up. Extra visits are important if there is a sudden increase in bone or joint pain, new swelling, signs of nerve compression like numbness or weakness, or fast changes in walking or hand use. These may signal fractures, nerve problems, or severe joint damage. malacards.org+1

Parents should seek medical advice if a child with PPHP shows delayed development, school difficulties, behaviour changes, or signs of depression or anxiety. Early psychological and educational support can make a big difference to long-term outcomes. Any planned surgery, pregnancy, or major new medicine should also be discussed with the specialist team to adjust treatments safely. Contact+2Genetic & Rare Diseases Center+2

---

What to eat and what to avoid

1. Eat plenty of calcium-rich foods – milk, yoghurt, cheese, tofu set with calcium, and leafy greens support bone health. Cleveland Clinic+1

2. Include vitamin D sources – oily fish, egg yolks, and fortified foods, plus safe sun exposure when possible, help maintain vitamin D levels. Cleveland Clinic+1

3. Choose lean protein – fish, poultry, beans, lentils, and nuts support muscle strength and tissue repair without too much saturated fat. National Organization for Rare Disorders+1

4. Focus on high-fibre foods – fruits, vegetables, whole grains, and legumes aid weight control and digestive health, important in people with low activity. National Organization for Rare Disorders+1

5. Limit sugary drinks and sweets – they add calories without nutrients and increase obesity risk, which worsens joint problems. National Organization for Rare Disorders+1

6. Avoid frequent fast food and deep-fried snacks – high salt and fat can harm heart health and weight control. National Organization for Rare Disorders+1

7. Moderate salt intake – too much salt may affect blood pressure and calcium balance; processed foods often hide large amounts. National Organization for Rare Disorders+1

8. Limit very high-phosphate soft drinks – excess phosphorus from sodas can affect calcium balance and bone health if intake is high. National Organization for Rare Disorders+1

9. Avoid crash diets – rapid weight loss can reduce muscle mass and bone density; slow, steady lifestyle changes are safer. National Organization for Rare Disorders+1

10. Be careful with “mega-dose” supplements – extra vitamins or minerals above recommended levels do not make bones stronger and may cause harm; always follow medical advice. StatPearls+1

---

Frequently asked questions

1. Is pseudopseudohypoparathyroidism life-threatening?
   PPHP itself is usually not life-threatening. It mainly affects body shape, bones, and sometimes learning. Serious problems are usually related to obesity, joint damage, or other diseases in the family, not PPHP alone. With good follow-up and healthy lifestyle, many people live a normal lifespan. Orpha+1

2. How is PPHP different from pseudohypoparathyroidism?
   Both conditions share the Albright hereditary osteodystrophy body features, but people with PPHP usually have normal calcium and hormone responses and do not need calcium and vitamin D treatment for hormone resistance. Pseudohypoparathyroidism has resistance to parathyroid hormone and often thyroid or other hormones, which needs specific endocrine therapy. NCBI+2NCBI+2

3. Can PPHP be cured?
   PPHP cannot be cured because it comes from a permanent gene change. However, many symptoms and complications can be managed, and quality of life can be high. Treatment focuses on pain control, joint protection, weight control, and support for learning and mental health. Nature+2Orpha+2

4. Will every child of a person with PPHP have the condition?
   PPHP is inherited in an autosomal dominant pattern, so each child has about a 50% chance of inheriting the GNAS gene change. Because of imprinting, whether the child develops PPHP, pseudohypoparathyroidism, or no symptoms depends on whether the mutation comes from the mother or father. Genetic counselling can explain the exact risks for a specific family. NCBI+2Genetic & Rare Diseases Center+2

5. Can lifestyle choices change the gene?
   Lifestyle choices cannot remove the gene mutation, but they can change how much the condition affects daily life. Healthy weight, good diet, regular exercise, and early therapies can greatly reduce pain, fatigue, and social difficulties. Contact+2National Organization for Rare Disorders+2

6. Does every person with PPHP have learning difficulties?
   No. Only a minority have intellectual disability or learning problems. Many people with PPHP have normal intelligence but may still need support for body image issues or chronic pain. Assessment is individual, and school support is based on the child’s actual needs, not just the diagnosis. Contact+2Genetic & Rare Diseases Center+2

7. Is there a special PPHP diet?
   There is no unique PPHP-only diet. Most experts recommend the same healthy pattern suggested for the general population: high in fruits, vegetables, whole grains, lean protein, and adequate calcium and vitamin D; low in added sugar, salt, and saturated fat. Adjustments are made if related endocrine problems exist. Cleveland Clinic+2National Organization for Rare Disorders+2

8. Do all people with PPHP need surgery?
   No. Many never need surgery. Operations are only considered for specific problems such as painful ossifications, severe bone deformity, or major dental issues. Non-surgical treatments are tried first, and the decision for surgery is made case by case. Orpha+2Orpha+2

9. Can children with PPHP play sports?
   Most children can take part in physical activities, but low-impact sports like swimming, cycling, and walking are usually better than high-impact contact sports. A physiotherapist or orthopaedic doctor can give personalised advice depending on joint condition and pain levels. Contact+1

10. Are there clinical trials for PPHP?
    Because PPHP is rare, there are few PPHP-only trials, but research is ongoing on the broader group of GNAS-related disorders and AHO. Rare disease registries and academic centres may offer observational studies or new treatment trials in the future. Families can ask their specialists or rare disease organisations about current studies. Nature+2National Organization for Rare Disorders+2

11. Can PPHP cause hormone problems later?
    PPHP itself classically does not cause hormone resistance, but some families carry mutations that, when inherited from the mother, can cause pseudohypoparathyroidism with hormone resistance. Family members need tailored endocrine evaluation depending on their genetic results and blood tests. NCBI+2NCBI+2

12. Does PPHP affect life expectancy?
    There is limited data, but PPHP does not seem to directly shorten life expectancy. However, obesity, limited mobility, or cardiovascular risk factors can affect long-term health. Managing weight, staying active, and controlling blood pressure, cholesterol, and blood sugar are important. Orpha+2Contact+2

13. Can PPHP be missed or misdiagnosed?
    Yes. Because it is rare, the body features may be mistaken for “normal family traits” or other bone conditions. Without genetic testing and careful clinical assessment, PPHP can be missed. Raising awareness among doctors and families helps earlier diagnosis and proper counselling. Jofem+2NCBI+2

14. Is it safe to become pregnant if I have PPHP?
    Many people with PPHP have successful pregnancies. However, short stature, obesity, and joint problems can increase pregnancy risks. Pre-pregnancy counselling with obstetric, endocrine, and genetic specialists is recommended to discuss inheritance, pregnancy risks, and delivery planning. Nature+2NCBI+2

15. Where can families find reliable information?
    Good sources include GeneReviews, Orphanet, national rare disease organisations, and peer-reviewed clinical guidelines on pseudohypoparathyroidism and related disorders. These sites give up-to-date, expert-checked information and patient-friendly summaries. NCBI+2Orpha+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December o3 , 2025.